Cargando…
Treatment of Porphyromonas gulae infection and downstream pathology in the aged dog by lysine‐gingipain inhibitor COR388
COR388, a small‐molecule lysine‐gingipain inhibitor, is currently being investigated in a Phase 2/3 clinical trial for Alzheimer's disease (AD) with exploratory endpoints in periodontal disease. Gingipains are produced by two species of bacteria, Porphyromonas gingivalis and Porphyromonas gulae...
Autores principales: | Arastu‐Kapur, Shirin, Nguyen, Mai, Raha, Debasish, Ermini, Florian, Haditsch, Ursula, Araujo, Joseph, De Lannoy, Ines A. M., Ryder, Mark I., Dominy, Stephen S., Lynch, Casey, Holsinger, Leslie J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6990966/ https://www.ncbi.nlm.nih.gov/pubmed/31999052 http://dx.doi.org/10.1002/prp2.562 |
Ejemplares similares
-
Alzheimer’s Disease-Like Neurodegeneration in Porphyromonas gingivalis Infected Neurons with Persistent Expression of Active Gingipains
por: Haditsch, Ursula, et al.
Publicado: (2020) -
Porphyromonas gingivalis in Alzheimer’s disease brains: Evidence for disease causation and treatment with small-molecule inhibitors
por: Dominy, Stephen S., et al.
Publicado: (2019) -
Adhesion and invasion of gingival epithelial cells by Porphyromonas gulae
por: Inaba, Hiroaki, et al.
Publicado: (2019) -
Phylogenomic analysis of the Porphyromonas gingivalis - Porphyromonas gulae duo: approaches to the origin of periodontitis
por: Morales-Olavarría, Mauricio, et al.
Publicado: (2023) -
Lipoprotein modifications by gingipains of Porphyromonas gingivalis
por: Lönn, J., et al.
Publicado: (2018)